Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia.

Madan V, Shyamsunder P, Han L, Mayakonda A, Nagata Y, Sundaresan J, Kanojia D, Yoshida K, Ganesan S, Hattori N, Fulton N, Tan KT, Alpermann T, Kuo MC, Rostami S, Matthews J, Sanada M, Liu LZ, Shiraishi Y, Miyano S, Chendamarai E, Hou HA, Malnassy G, Ma T, Garg M, Ding LW, Sun QY, Chien W, Ikezoe T, Lill M, Biondi A, Larson RA, Powell BL, Lübbert M, Chng WJ, Tien HF, Heuser M, Ganser A, Koren-Michowitz M, Kornblau SM, Kantarjian HM, Nowak D, Hofmann WK, Yang H, Stock W, Ghavamzadeh A, Alimoghaddam K, Haferlach T, Ogawa S, Shih LY, Mathews V, Koeffler HP.

Leukemia. 2016 Aug;30(8):1672-81. doi: 10.1038/leu.2016.69.

2.

The leukemic oncoprotein NPM1-RARA inhibits TP53 activity.

Swaney EM, Chattopadhyay A, Abecassis I, Rush EA, Redner RL.

Leuk Lymphoma. 2016 Aug;57(8):1933-7. doi: 10.3109/10428194.2015.1124992.

PMID:
26754533
3.
4.

Global characteristics of childhood acute promyelocytic leukemia.

Zhang L, Samad A, Pombo-de-Oliveira MS, Scelo G, Smith MT, Feusner J, Wiemels JL, Metayer C.

Blood Rev. 2015 Mar;29(2):101-25. doi: 10.1016/j.blre.2014.09.013. Review.

6.

The PML domain of PML-RARα blocks senescence to promote leukemia.

Korf K, Wodrich H, Haschke A, Ocampo C, Harder L, Gieseke F, Pollmann A, Dierck K, Prall S, Staege H, Ma H, Horstmann MA, Evans RM, Sternsdorf T.

Proc Natl Acad Sci U S A. 2014 Aug 19;111(33):12133-8. doi: 10.1073/pnas.1412944111.

7.

Acute Myelogenous Leukemia without Maturation with a Retinoic Alpha-Receptor Deletion: A Case Report.

Trosclair C, Pollen M, Capraro G, Cotelingam J, Shackelford RE.

Case Rep Oncol. 2014 Jun 25;7(2):407-9. doi: 10.1159/000365002.

8.

Extrinsic apoptosis is impeded by direct binding of the APL fusion protein NPM-RAR to TRADD.

Chattopadhyay A, Hood BL, Conrads TP, Redner RL.

Mol Cancer Res. 2014 Sep;12(9):1283-91. doi: 10.1158/1541-7786.MCR-14-0080.

9.

Perspectives of differentiation therapies of acute myeloid leukemia: the search for the molecular basis of patients' variable responses to 1,25-dihydroxyvitamin d and vitamin d analogs.

Marchwicka A, Cebrat M, Sampath P, Snieżewski L, Marcinkowska E.

Front Oncol. 2014 May 27;4:125. doi: 10.3389/fonc.2014.00125. Review.

10.

Synergy against PML-RARa: targeting transcription, proteolysis, differentiation, and self-renewal in acute promyelocytic leukemia.

Dos Santos GA, Kats L, Pandolfi PP.

J Exp Med. 2013 Dec 16;210(13):2793-802. doi: 10.1084/jem.20131121. Review.

11.

Differentiation therapy of acute myeloid leukemia.

Gocek E, Marcinkowska E.

Cancers (Basel). 2011 May 16;3(2):2402-20. doi: 10.3390/cancers3022402.

12.

Interaction with RXR is necessary for NPM-RAR-induced myeloid differentiation blockade.

Rush EA, Pollock SL, Abecassis I, Redner RL.

Leuk Res. 2013 Dec;37(12):1704-10. doi: 10.1016/j.leukres.2013.09.024.

13.

How I treat children and adolescents with acute promyelocytic leukaemia.

Abla O, Ribeiro RC.

Br J Haematol. 2014 Jan;164(1):24-38. doi: 10.1111/bjh.12584. Review.

14.

Molecular basis for the diagnosis and treatment of acute promyelocytic leukemia.

Bassi SC, Rego EM.

Rev Bras Hematol Hemoter. 2012;34(2):134-9. doi: 10.5581/1516-8484.20120033.

15.

An optimized technology platform for the rapid multiplex molecular analysis of genetic alterations associated with leukemia.

Ye F, Laosinchai-Wolf W, Labourier E.

Cancer Genet. 2012 Oct;205(10):488-500. doi: 10.1016/j.cancergen.2012.06.006.

16.

Acute promyelocytic leukemia: an experience on 95 greek patients treated in the all-trans-retinoic Acid era.

Pagoni M, Garofalaki M, Panitsas F, Manola K, Psarra K, Economopoulos P, Vourtsi A, Antoniades M, Gkirkas K, Tzouvara E, Katis F, Prokopiou C, Tziotziou I, Balta A, Lemissiou E, Tsirigotis P, Repoussis P, Harhalakis N.

Mediterr J Hematol Infect Dis. 2011;3(1):e2011053. doi: 10.4084/MJHID.2011.053.

17.

Characterization of cryptic rearrangements, deletion, complex variants of PML, RARA in acute promyelocytic leukemia.

Amare PK, Baisane C, Nair R, Menon H, Banavali S, Kabre S, Gujral S, Subramaniam P.

Indian J Hum Genet. 2011 May;17(2):54-8. doi: 10.4103/0971-6866.86174.

18.
19.

Cryptic insertion of PML-RARA into the 3p25 locus in an acute promyelocytic leukemia with t(3;17)(p25;q21).

Chattopadhyay A, Redner RL.

Cancer Genet Cytogenet. 2010 Aug;201(1):28-31. doi: 10.1016/j.cancergencyto.2010.05.001.

20.
Items per page

Supplemental Content

Support Center